3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Neoplasms
11
Breast Neoplasms
8
Colonic Neoplasms
7
Lung Neoplasms
5
Brain Neoplasms
4
Urinary Bladder Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Carcinoma, Hepatocellular
3
Respiratory Aspiration
2
Rectal Neoplasms
2
Prostatic Neoplasms
2
Postoperative Complications
2
Pituitary Neoplasms
2
Ovarian Neoplasms
2
Neoplastic Cells, Circulating
2
Melanoma
2
Uterine Neoplasms
1
Thyroid Nodule
1
Thyroid Neoplasms
1
Recurrence
1
Quality of Recovery
1
Postoperative Cognitive Complications
1
Pain, Postoperative
1
Neurofibromatoses
1
Neoplasm Metastasis
1
Myofibroma
1
Lymphoma, Follicular
1
Liver Neoplasms
1
Liver Functions Tests
1
Kidney Neoplasms
1
Interventions
Bupivacaine
11
Ketamine
9
Ropivacaine
8
Morphine
8
Acetaminophen
8
Fentanyl
7
Dexmedetomidine
7
Lidocaine
6
Anesthesia, General
6
Analgesics, Opioid
6
Saline Solution
5
Anesthesia, Local
5
Acupuncture Therapy
5
parecoxib
4
Tramadol
4
Sodium Chloride
4
Pregabalin
4
Ethanol
4
Analgesia, Epidural
4
Transcutaneous Electric Nerve Stimulation
3
Radiofrequency Ablation
3
Propofol
3
Oxycodone
3
Ketorolac
3
Control Groups
3
Anesthetics, Local
3
trimebutine 3-thiocarbamoylbenzenesulfonate
2
Therapeutics
2
Surveys and Questionnaires
2
Magnesium Sulfate
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Agnosia
×
Sevoflurane
×
Clear all
NCT00531349
2016-05-09
ECA/R
The Cleveland Clinic
Phase 3
Withdrawn